What Connect Biopharma Holdings Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 0 |
| Total trades | 2 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 8 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Xanthopoulos Kleanthis Gabriel | Director | Sep 30 | Grant / award · A | +5,000 | — | — | 91,554 |
| Liu Jean I | Director | Sep 30 | Grant / award · A | +8,984 | — | — | 20,763 |
| Xanthopoulos Kleanthis Gabriel | Director | Jun 30 | Grant / award · A | +3,738 | — | — | 86,554 |
| Liu Jean I | Director | Jun 30 | Grant / award · A | +6,718 | — | — | 11,779 |
| Huang James | Director | May 29 | Open-market buy · P | +150,000 | $2.48 | +$372K | 13,310,000 |
| Xanthopoulos Kleanthis Gabriel | Director | Mar 31 | Grant / award · A | +2,816 | — | — | 82,816 |
| Huang James | Director | Mar 31 | Open-market buy · P | +1,160,000 | $3.45 | +$4M | 13,160,000 |
| Liu Jean I | Director | Mar 31 | Grant / award · A | +5,061 | — | — | 5,061 |
Loading...
